ARTICLE | Financial News
Eleven Biotherapeutics completes IPO
February 10, 2014 8:00 AM UTC
Eleven Biotherapeutics Inc. (NASDAQ:EBIO), Cambridge, Mass. Business: Ophthalmic Date completed: 2/6/14 Type: IPO Raised: $50 million Shares: 5 million Price: $10 Shares after offering: 15.4 million U...